Nanoscale Diagnostics for Antigen-Specific Cells and Monitoring the Progress of an Immunotherapy

Immunotherapy is a revolutionary approach to treat diseases like cancer and autoimmune disorders by utilizing the immune system’s natural defense mechanisms. Various types of immunotherapies with distinct mechanistic approaches are currently used in numerous applications. The most prevalent category includes immunological blockers of checkpoints, such as inhibitors targeting programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), that confidently stimulate the tendency of the immune system to detect and combat malignant cells. It includes immunological checkpoint blockers, monoclonal antibodies, adoptive cell therapies, and vaccines. These strategies are transforming medical treatments and providing new hope to patients with challenging diseases, reshaping the medical landscape. Nanotechnology is revolutionizing immunotherapy monitoring by enhancing treatment precision, effectiveness, and efficiency through targeted drug delivery, real-time imaging, and biomarker detection. Nano-scale diagnostics are revolutionizing immunotherapy monitoring, providing real-time analysis of immune responses. Despite challenges like sample preparation and data analysis complexity, advancements in nanotechnology and bioinformatics are expected to address these limitations, offering personalized treatment options for diseases like cancer and autoimmune disorders.